{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:34:41Z","timestamp":1781105681048,"version":"3.54.1"},"reference-count":60,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1297\/cpe.2022-0034","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T18:22:52Z","timestamp":1657822972000},"page":"211-224","source":"Crossref","is-referenced-by-count":4,"title":["Changes, limitations, and prospects of adult height in GH treatment for Japanese GHD patients"],"prefix":"10.1297","volume":"31","author":[{"given":"Toshiaki","family":"Tanaka","sequence":"first","affiliation":[{"name":"Tanaka Growth Clinic, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tanaka, T. History of GH treatment in Japan. Clin Pediatr Endocrinol 2022;31: 1\u20139.","DOI":"10.1297\/cpe.2021-0044"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tanaka, T, Tachibana, K, Shimatsu, A, Katsumata, N, Tsushima, T, Hizuka, N, et al. A nationwide attempt to standardize growth hormone assays. Horm Res 2005;64(Suppl 2): 6\u201311.","DOI":"10.1159\/000087746"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tanaka, T, Takano, K, Hanew, K, Nishi, Y, Igarashi, Y, Hirano, T, et al. Registration system for growth hormone (GH) treatment with standardized immunoreactive GH values in Japan. Endocr J 1998;45: 459\u201365.","DOI":"10.1507\/endocrj.45.459"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hibi, I, Tanaka, T and Committee for Treatment of Growth Hormone Deficient Children. Foundation of growth science: final height of patients with idiopathic growth hormone deficiency after long-term growth hormone treatment. Acta Endocrinol 1989;120: 409\u201315.","DOI":"10.1530\/acta.0.1200409"},{"key":"5","unstructured":"5. Tanaka, T, Tachibana, K, Hirano, T. Report from Registration System Study Committee, The foundation for growth science. Annual Research Report 1996;20: 1\u201318."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Isojima, T, Hasegawa, T, Yokoya, S, Tanaka, T. Demographic characteristics of children with growth hormone deficiency from 1996 to 2015 in Japan: 20 years of data from the foundation for growth science in Japan. Endocr J 2022; EJ21\u20130520.","DOI":"10.1507\/endocrj.EJ21-0520"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tanaka, T, Hanew, K, Nishi, Y, Tachibana, K, Yokoya, S, Igarashi, Y, et al. Final height of growth hormone (GH)-treated short children registered at the Foundation for Growth Science in Japan: Comparison between the pituitary human GH era and the recombinant human GH era. Clin Pediatr Endocrinol 2001;10: 53\u201362.","DOI":"10.1297\/cpe.10.53"},{"key":"8","unstructured":"8. Ogawa, M, Nose, O, Okada, T, Kamijo, T, Kinoshita, E, Tokuda, M, et al. Improvement of adult height in GH-treated idiopathic growth hormone deficiency. J Jpn Pediatr Soc 2012;116: 979\u201384 (in Japanese)."},{"key":"9","unstructured":"9. Tanaka, T, Nakano, Y, Nose, O, Tokuda, M, Kinoshita, E, Tsuru, N, et al. A 2016 survey on adult height after growth hormone treatment in patients with idiopathic growth hormone deficiency: Combination treatment with anabolic steroid hormone improves adult height in boys. J Jpn Ass Hum Auxo 2018;24: 35\u201342."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fujieda, K, Tanaka, T, Takano, K, Chihara, K, Seino, Y, Irie, M, KIGS Japan Scientific Committee. Adult height after growth hormone treatment in Japanese children with idiopathic growth hormone deficiency: analysis from the KIGS Japan database. J Pediatr Endocrinol Metab 2011;24: 457\u201362.","DOI":"10.1515\/jpem.2011.212"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hibi, I. The birth injury theory of \u201cidiopathic\u201d growth hormone deficiency. Clin Pediatr Endocrinol 1992;1: 1\u20133.","DOI":"10.1297\/cpe.1.1"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Inoue, Y, Nemoto, Y, Fujita, K, Aoki, H, Takemoto, K, Tsukamoto, Y, et al. Pituitary dwarfism: CT evaluation of the pituitary gland. Radiology 1986;159: 171\u20133.","DOI":"10.1148\/radiology.159.1.3952303"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fujiwara, I, Kikuchi, K, Nishimura, K, Togashi, K, Itoh, K, Noma, S, et al. Transection of the pituitary stalk; Development of an ectopic posterior lobe assessed with MRI imaging. Radiology 1987;165: 486\u20139.","DOI":"10.1148\/radiology.165.2.3659371"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kikuchi, K, Fujisawa, I, Momoi, T, Yamanaka, C, Kaji, M, Nakano, Y, et al. Hypothalamic-pituitary function in growth hormone-deficient patients with pituitary stalk transection. J Clin Endocrinol Metab 1988;67: 817\u201323.","DOI":"10.1210\/jcem-67-4-817"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Koch, TK, Berg, BO, De Armond, SJ, Gravina, RF. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med 1985;313: 731\u20133.","DOI":"10.1056\/NEJM198509193131206"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gibbs, CJ, Joy, A, Heffner, R, Franko, M, Miyazaki, M, Asher, DM, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 1985;313: 734\u20138.","DOI":"10.1056\/NEJM198509193131207"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Powell-Jackson, J, Weller, RO, Kennedy, P, Preece, MA, Whitcombe, EM, Newsom-Davis, J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985;2: 244\u20136.","DOI":"10.1016\/S0140-6736(85)90292-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. J\u00f8rgensen, JO, M\u00f8ller, J, M\u00f8ller, N, Lauritzen, T, Christiansen, JS. Pharmacological aspects of growth hormone replacement therapy: route, frequency and timing of administration. Horm Res 1990;33(Suppl 4): 77\u201382.","DOI":"10.1159\/000181589"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hindmarsh, PC, Stanhope, R, Preece, MA, Brook, CG. Frequency of administration of growth hormone--an important factor in determining growth response to exogenous growth hormone. Horm Res 1990;33(Suppl 4): 83\u20139.","DOI":"10.1159\/000181590"},{"key":"20","unstructured":"20. Tanaka, T. Comparison of diagnostic criteria for GHD between Japan and other countries. Clin Pediatr Endocrinol 1999;8(suppl 13): 59\u201365."},{"key":"21","unstructured":"21. Bristow, AF, Schulster, D, Jeffcoate, S. Report of an International Workshop on assays, standardization and labelling requirements of somatropin. Pharmaeuropa  1994;6: 60-7."},{"key":"22","unstructured":"22. Takano, K, Tanaka, T, Hanew, K, Hirano, T, Igarashi, Y, Nishi, Y, et al. Final height achieved with GH treatment in cases of short stature due to GH secretion deficiency \u2013 Ten years of recent cases. Clin Pediatr Endocrinol 1999;8(Suppl 13): 29\u201335."},{"key":"23","unstructured":"23. Tanaka, T, Takano, K, Igarashi, Y, Hanew, K, Nishi, Y, Tachibana, K, et al. Growth hormone (GH) treatment and puberty in GH-treated GH deficient children. Clin Pediatr Endocrinol 1999;8(suppl 13): 37\u201344."},{"key":"24","unstructured":"24. Tanaka, T, Fujieda, K, Seino, Y, Takano, K, Chihara, I, Irie, M. Short- and long-term effects of human growth hormone in growth hormone deficient short children: Analysis of KIGS data base. J Jpn Ass Hum Auxo 2010;16: 69\u201376 (in Japanese)."},{"key":"25","unstructured":"25. Tanaka, T, Hasegawa, T, Ozono, K, Tanaka, H, Kanzaki, S, Yokoya, S, et al. Effect of growth hormone treatment on adult height in patients with GH deficiency: the Japanese cohort from the GeNeSIS observational study. J Jpn Ass Hum Auxo 2020;26: 28\u201337."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tanaka, T. Growth hormone secretion and the therapeutic effects of human growth hormone: first Japanese results of the Kabi Pharmacia International Growth Study\/International Cooperative Growth Study. Acta Paediatr Scand Suppl 1991;379(Supple 379): 126\u201335.","DOI":"10.1111\/j.1651-2227.1991.tb12063.x"},{"key":"27","unstructured":"27. Fujieda, K, Hanew, K, Hirano, T, Igarashi, Y, Nishi, Y, Tachibana, K, et al. Three-year growth response to growth hormone therapy in patients with different degree of growth hormone deficiency: analysis of the Japanese International Cooperative Growth Study. Clin Pediatr Endocrinol 1999;8(supple 13): 23\u20138."},{"key":"28","unstructured":"28. Tanaka, T, Fujieda, K, Hanew, K, Nishi, Y, Tachibana, K, Yokoya, S, et al. Normalization of final height after recombinant human growth hormone (GH) treatment in GH-treated short children. J Jpn Pediatr Soc 2001;105: 546\u201351 (in Japanese)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Radetti, G, Buzi, F, Paganini, C, Pilotta, A, Felappi, B. Treatment of GH-deficient children with two different GH doses: effect on final height and cost-benefit implications. Eur J Endocrinol 2003;148: 515\u20138.","DOI":"10.1530\/eje.0.1480515"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Maghnie, M, Ambrosini, L, Cappa, M, Pozzobon, G, Ghizzoni, L, Ubertini, MG, et al. Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies. J Clin Endocrinol Metab 2006;91: 2900\u20135.","DOI":"10.1210\/jc.2006-0050"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Reiter, EO, Price, DA, Wilton, P, Albertsson-Wikland, K, Ranke, MB. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab 2006;91: 2047\u201354.","DOI":"10.1210\/jc.2005-2284"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Rachmiel, M, Rota, V, Atenafu, E, Daneman, D, Hamilton, J. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone. Horm Res 2007;68: 236\u201343.","DOI":"10.1159\/000101427"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Pf\u00e4ffle, R, Land, C, Sch\u00f6nau, E, Holterhus, PM, Ross, JL, Piras de Oliveira, C, et al. Growth hormone treatment for short stature in the USA, Germany, and France: 15 years of surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS). Horm Res Paediatr 2018;90: 169\u201380.","DOI":"10.1159\/000492397"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Deal, C, Kirsch, S, Chanoine, JP, Lawrence, S, Cummings, E, Rosolowsky, ET, et al. GeNeSIS National Board on behalf of the GeNeSIS Canada Investigators. Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study. CMAJ Open 2018;6: E372\u201383.","DOI":"10.9778\/cmajo.20180020"},{"key":"35","unstructured":"35. Tanaka, T. International comparison of adult height in children with growth hormone deficiency and limitations of growth hormone treatment in Japan. Pediatr Endocrinol Rev 2017;14(Suppl 1): 216\u201321."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Hashimoto, Y, Kamioka, T, Hosaka, M, Mabuchi, K, Mizuchi, A, Shimazaki, Y, et al. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men. J Clin Endocrinol Metab 2000;85: 601\u20136.","DOI":"10.1210\/jcem.85.2.6377"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Martha, PM, Gorman, KM, Blizzard, RM, Rogol, AD, Veldhuis, JD. Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. J Clin Endocrinol Metab 1992;74: 336\u201344.","DOI":"10.1210\/jcem.74.2.1730812"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Burns, EC, Tanner, JM, Preece, MA, Cameron, N. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr 1981;137: 155\u201364.","DOI":"10.1007\/BF00441309"},{"key":"39","unstructured":"39. Price, DA, Ranke, MB. Final height following growth hormone treatment. In: Ranke MB, Gunnarsson R, editors. Progress in Growth Hormone Therapy-5 years of KIGS. Mannheim: J&J Verlag;  1994.p.129\u201344."},{"key":"40","unstructured":"40. Tanaka, T. Pubertal aspects of idiopathic growth hormone deficiency. In: Ranke MB, Gunnarsson R, editors. Progress in growth hormone therapy \u2013 5 years of KIGS. Mannheim, Germany: J & J Verlag; 1994.p.112\u201328."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Tanaka, T, Yoshizawa, A, Tanae, A, Hibi, I, Shizume, K. Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy. Horm Res 1990;33(Suppl 4): 102\u20135.","DOI":"10.1159\/000181593"},{"key":"42","unstructured":"42. Tanaka, T, Ito, J, Kanzaki, S, Shimatsu, A, Tanaka, H, Teramoto, A, et al. The effect of growth hormone (GH) therapy in prepubertal short children with GH deficiency. J Jpn Ass Hum Auxo 2010;16: 23\u20139."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Tanaka, T, Soneda, S, Sato, N, Kishi, K, Noda, M, Ogasawara, A. Early growth hormone treatment accelerates delayed onset of puberty in patients with growth hormone deficiency. Endocr J 2022;69: 199\u2013207.","DOI":"10.1507\/endocrj.EJ21-0209"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Naiki, Y, Horikawa, R, Tanaka, T, Child Health and Development Network. Assessment of psychosocial status among short-stature children with and without growth hormone therapy. Clin Pediatr Endocrinol 2013;22: 25\u201332 (in Japanese).","DOI":"10.1297\/cpe.22.25"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Tanaka, T, Soneda, S, Sato, N, Kishi, K, Noda, M, Ogasawara, A, et al. The boy:girl ratio of children diagnosed with growth hormone deficiency-induced short stature is associated with the boy:girl ratio of children visiting short stature clinics. Horm Res Paediatr 2021;94: 211\u20138.","DOI":"10.1159\/000518995"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Stanhope, R, Uruena, M, Hindmarsh, P, Leiper, AD, Brook, CGD. Management of growth hormone deficiency through puberty. Acta Paediatr Scand Suppl 1991;372(suppl): 47\u201352, discussion 53.","DOI":"10.1111\/j.1651-2227.1991.tb17969.x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Albertsson-Wikland, K, Alm, F, Aronsson, S, Gustafsson, J, Hagen\u00e4s, L, H\u00e4ger, A, et al. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens. Acta Paediatr 1999;88(suppl): 80\u20134.","DOI":"10.1111\/j.1651-2227.1999.tb14358.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Hibi, I, Tanaka, T, Tanae, A, Kagawa, J, Hashimoto, N, Yoshizawa, A, et al. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children. J Clin Endocrinol Metab 1989;69: 221\u20136.","DOI":"10.1210\/jcem-69-2-221"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Tanaka, T, Satoh, M, Yasunaga, T, Horikawa, R, Tanae, A, Hibi, I. GH and GnRH analog treatment in children who enter puberty at short stature. J Pediatr Endocrinol Metab 1997;10: 623\u20138.","DOI":"10.1515\/JPEM.1997.10.6.623"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Tanaka, T, Satoh, M, Hibi, I. Combined GH and LHRH analog treatment can increase pubertal growth in short children. Clin Pediatr Endocrinol 1997;6(suppl 9): 39\u201344.","DOI":"10.1297\/cpe.6.Supple9_39"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Tanaka, T. Combination treatment of GH and LHRH analog to increase pubertal growth for GHD children who enter puberty with short stature. Clin Pediatr Endocrinol 2005;14(supple 24): S24_7\u201316.","DOI":"10.1297\/cpe.14.S24_7"},{"key":"52","unstructured":"52. Tanaka, T. Sufficiently long-term treatment with combined growth hormone and gonadotropin-releasing hormone analog can improve adult height in short children with isolated growth hormone deficiency (GHD) and in non-GHD short children. Pediatr Endocrinol Rev 2007;5: 471\u201381."},{"key":"53","unstructured":"53. Tanaka, T, Sato, N, Ogasawara, A, Noda, M, Naiki, Y, Horikawa, R. The effects of combination treatment of growth hormone and anabolic steroid hormone on adult height in boys with growth hormone deficiency. J Jpn Ass Hum Auxo 2017;23: 21\u201330."},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Smith, EP, Boyd, J, Frank, GR, Takahashi, H, Cohen, RM, Specker, B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331: 1056\u201361.","DOI":"10.1056\/NEJM199410203311604"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Morishima, A, Grumbach, MM, Simpson, ER, Fisher, C, Qin, K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80: 3689\u201398.","DOI":"10.1210\/jcem.80.12.8530621"},{"key":"56","unstructured":"56. Naiki, Y, Ito, M, Yoshimura, K, Sato, M, Ikema, N, Horikawa, R, et al. Growth promotion effect of an anabolic steroid on boys in puberty Jpn J. Dev Pharmacol Ther 2005;18: 143\u20136 (in Japanese)."},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Otsuka, F, Takahashi, Y, Tahara, S, Ogawa, Y, H\u00f8jby Rasmussen, M, Takano, K. Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once-weekly somapacitan or daily growth hormone. Clin Endocrinol (Oxf) 2020;93: 620\u20138.","DOI":"10.1111\/cen.14273"},{"key":"58","unstructured":"58. Horikawa, R, Tanaka, T, Hasegawa, Y, Yorifuji, T, Ng, D, Rosenfgeld, RG, et al. Efficacy and safety of once-weekly somatrogon compared with once-daily somatropin (Genotropin\u00ae) in Japanese children with pediatric growth hormone deficiency: results from a randomized phase 3 study. Horm Res Paediatr."},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Tanaka, T, Sato, T, Yuasa, A, Akiyama, T, Tawseef, A. Patient preferences for growth hormone treatment in Japanese children. Pediatr Int 2021;63: 1185\u201391.","DOI":"10.1111\/ped.14760"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. S\u00e4vendahl, L, Battelino, T, Brod, M, H\u00f8jby Rasmussen, M, Horikawa, R, Juul, RV, et al. REAL 3 study group. Once-weekly somapacitan vs daily GH in children with GH deficiency: Results from a randomized phase 2 trial. J Clin Endocrinol Metab 2020;105: e1847\u201361.","DOI":"10.1210\/clinem\/dgaa614"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/31\/4\/31_2022-0034\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:37:32Z","timestamp":1664584652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/31\/4\/31_2022-0034\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2022-0034","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"2022-0034"}}